Organization: TriFund Capital Ltd

NeuroMed takes top spot with US$32M financing round

NeuroMed Technologies Inc has scored the largest private biotech financing in Canada this year, raising US$32 million for development of its next-generation chronic pain drugs. Proceeds will be used to move the Vancouver-based company’s lead compound to completion of Phase II clinical trials, and to fund further development of its preclinical pipeline. Investors in the…